• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SOPHiA GENETICS SA - Ordinary Shares (NQ:SOPH)

4.190 -0.120 (-2.78%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about SOPHiA GENETICS SA - Ordinary Shares

< Previous 1 2 3 4 Next >
2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores
October 03, 2025
Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge Stock Rankings. 
Via Benzinga
Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI
October 01, 2025
San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
SOPHiA GENETICS SA (NASDAQ:SOPH) Beats Q2 2025 Earnings Estimates, Shares Jump in Pre-Market Trading
August 05, 2025
SOPHiA GENETICS beats Q2 2025 estimates with $18.32M revenue and $0.33 EPS, driving shares up 5.45% in pre-market trading. 
Via Chartmill
Earnings Scheduled For August 5, 2025
August 05, 2025
 
Via Benzinga
Earnings Scheduled For May 6, 2025
May 06, 2025
 
Via Benzinga
Exploring Sophia Genetics's Earnings Expectations
November 04, 2024
 
Via Benzinga
Preview: Sophia Genetics's Earnings
March 04, 2024
 
Via Benzinga
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
September 23, 2025
From Myriad Genetics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 17, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 15, 2025
 
Via Benzinga
Earnings Scheduled For March 4, 2025
March 04, 2025
 
Via Benzinga
SOPH Stock Earnings: Sophia Genetics Beats EPS, Misses Revenue for Q2 2024
August 06, 2024
SOPH stock results show that Sophia Genetics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting
June 24, 2024
Shareholders adopt all proposals at Annual General Meeting 
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
Why Nvidia Stock Investors Should Be Excited About an Upcoming IPO
May 30, 2024
CoreWeave, a company backed by Nvidia, is preparing to go public in 2025. 
Via The Motley Fool
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 29, 2024
 
Via Benzinga
Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday
May 29, 2024
 
Via Benzinga
SOPH Stock Earnings: Sophia Genetics Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
SOPH stock results show that Sophia Genetics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
SOPHiA GENETICS Reports First Quarter 2024 Results
May 07, 2024
Consistent Operational Execution; Robust New Business Momentum; Guidance Reaffirmed 
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference
April 30, 2024
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
April 23, 2024
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
March 18, 2024
 
Via Benzinga
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
March 07, 2024
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
Why CrowdStrike Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
March 06, 2024
Shares of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) shares surged 24.4% to $370.27 in pre-market trading after the company reported better-than-expected fourth-quarter earnings and revenues and issued... 
Via Benzinga
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 06, 2024
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 06, 2024
We're starting Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning! 
Via InvestorPlace
Oddity Tech Posts Q4 Results, Joins Ross Stores And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
March 06, 2024
U.S. stock futures were higher this morning, with the Nasdaq futures gaining by around 100 points on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 05, 2024
 
Via Benzinga
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
March 05, 2024
Strong momentum to continue in 2024 as SOPHiA GENETICS announces record revenue, 35 new customer additions in Q4, and 36% cash burn decline in FY 2023 
From SOPHiA GENETICS, Inc.
Via GlobeNewswire
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 05, 2024
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
Via Benzinga
Earnings Scheduled For March 5, 2024
March 05, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. 
Via Benzinga
< Previous 1 2 3 4 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap